FDA updates Merck's Winrevair label with early PAH trial data

September 22, 2026 6:45 AM

The U.S. Food and Drug Administration has approved an update to the product label for Merck's (NYSE: MRK) Winrevair (sotatercept-csrk) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found